The Boston Globe Features Target ALS Founder, Dan Doctoroff

April 26, 2019

By Jonathan Saltzman, Globe Staff

Read the full Boston Globe story here.

Tags

Related News

The ALS Global Research Initiative: Pioneering ALS Research Across the Globe

January 27, 2026

Inside a Global Effort to Understand ALS Resilience

January 27, 2026

Target ALS and Regeneron Partner to Expand Access to a Novel C9orf72 ALS/FTD Mouse Model

January 27, 2026

Target ALS Grantee NRG Therapeutics Advances NRG5051 into Phase I Clinical Trial

January 26, 2026